Heuron Hosts Delegation from Uzbekistan Ministry of Health for Discussions on Stroke AI Adoption

Aug. 2025

Exploring AI Adoption, Research, and Policy Integration with Senior Officials and Medical Experts from Uzbekistan




Heuron Co., Ltd. (CEO Dong Hoon shin) announced that officials from the Ministry of Health of the Republic of Uzbekistan and medical professionals recently visited the company’s headquarters to discuss the introduction of Heuron’s stroke AI solutions and possible cooperation.


The visitors included Dr. Ismailov Uktam Safaevich, Head of the Department of Science, Education and Innovation at the Ministry of Health of the Republic of Uzbekistan, and Professor Dr. Sharipov Alisher Mirkhamidovich, Head of the Department of Emergency Medicine at the Tashkent Pediatric Research Institute. They examined Heuron’s AI-based stroke diagnosis and treatment support solutions and held discussions on their potential implementation in Uzbekistan.


The meeting addressed several key topics, including: sharing the current situation of stroke diagnosis and treatment in Uzbekistan; possible applications of Heuron’s AI solutions in the country’s standard stroke care process; budget considerations for adoption; initiation of related joint research; and concrete measures for establishing long-term cooperation.


Uzbekistan has been actively working to improve its healthcare system in response to the growing number of cerebrovascular disease patients, and this visit to Heuron was part of such efforts. Heuron proposed tailored approaches for applying its AI solutions in line with local medical infrastructure and clinical processes, laying the foundation for collaboration.


A Heuron official stated, “This visit demonstrates that the Government of Uzbekistan is actively pursuing the introduction of AI-based stroke solutions to strengthen its national healthcare system. Heuron will cooperate closely with Uzbekistan’s medical experts to apply technology suited to the country’s clinical standards and contribute to practical improvements in patient care.”

TOP